Eagle Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
Eagle Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $413.00 thousand as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2023-08-09
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $413.00K.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $413.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.12M.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.12M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2023-06-30 | $413.00K 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $413.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.12M 10-K · filed 2023-03-23 |
| 2022-09-30 | $1.12M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.12M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.04M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.46M 10-K · filed 2022-03-08 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.46M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.46M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.42M 10-K · filed 2021-03-05 |
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.36M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.36M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $1.34M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $864.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $864.00K 10-Q · filed 2019-05-07 |